FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-kappa B-RIPK1-caspase axis

Changbo Qu, Yang Li, Yunlong Li, Peifa Yu, Pengfei Li, JM Donkers, SFJ van de Graaf, Rob de Man, Maikel Peppelenbosch, Qiuwei Pan

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Scopus)
14 Downloads (Pure)
Original languageUndefined/Unknown
Article number104588
JournalAntiviral Research
Volume170
DOIs
Publication statusPublished - 2019

Research programs

  • EMC MM-04-20-02-A

Cite this